Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie Binley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Opinion in Molecular Therapeutics|February 6, 2004
Exploiting the hypoxia responseKatie Binley, On Kan, Jonathon White, et al.
Lancet (London, England)|August 28, 2015
Use of magnetic nanoparticles and oscillating magnetic field for non-viral gene transfer into mouse corneaWai Siene Ng, Katie Binley, Bing Song, et al.
Clinical Science (London, England : 1979)|December 13, 2005
Gene therapy for neurodegenerative and ocular diseases using lentiviral vectorsG Scott Ralph, Katie Binley, Liang-Fong Wong, et al.
Molecular Therapy. Nucleic Acids|December 13, 2012
Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In VivoScott Ellis, Liang Fong-Wong, Sharifah Iqball, et al.
International Journal of Molecular Medicine|December 18, 2010
Genetically modified macrophages expressing hypoxia regulated cytochrome P450 and P450 reductase for the treatment of cancerOn Kan, Debbie Day, Sharifah Iqball, et al.
The Journal of Gene Medicine|October 30, 2007
Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptorsMarjorie Nicoud, Jian Kong, Sharifah Iqball, et al.
Investigative Ophthalmology & Visual Science|June 27, 2007
Cryopreservation and lentiviral-mediated genetic modification of human primary cultured corneal endothelial cellsLeejee H Suh, Cheng Zhang, Roy S Chuck, et al.
Human Gene Therapy|April 10, 2010
Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularizationShu Kachi, Katie Binley, Katsutoshi Yokoi, et al.
Human Gene Therapy|January 25, 2018
Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant PatientsNaghmeh Fouladi, Maria Parker, Vicky Kennedy, et al.
Genomics|December 12, 2003
Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesisJonathan Richard White, Robert A Harris, Sheena R Lee, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Opinion in Molecular Therapeutics|February 6, 2004
Exploiting the hypoxia responseKatie Binley, On Kan, Jonathon White, et al.
Lancet (London, England)|August 28, 2015
Use of magnetic nanoparticles and oscillating magnetic field for non-viral gene transfer into mouse corneaWai Siene Ng, Katie Binley, Bing Song, et al.
Clinical Science (London, England : 1979)|December 13, 2005
Gene therapy for neurodegenerative and ocular diseases using lentiviral vectorsG Scott Ralph, Katie Binley, Liang-Fong Wong, et al.
Molecular Therapy. Nucleic Acids|December 13, 2012
Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In VivoScott Ellis, Liang Fong-Wong, Sharifah Iqball, et al.
International Journal of Molecular Medicine|December 18, 2010
Genetically modified macrophages expressing hypoxia regulated cytochrome P450 and P450 reductase for the treatment of cancerOn Kan, Debbie Day, Sharifah Iqball, et al.
The Journal of Gene Medicine|October 30, 2007
Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptorsMarjorie Nicoud, Jian Kong, Sharifah Iqball, et al.
Investigative Ophthalmology & Visual Science|June 27, 2007
Cryopreservation and lentiviral-mediated genetic modification of human primary cultured corneal endothelial cellsLeejee H Suh, Cheng Zhang, Roy S Chuck, et al.
Human Gene Therapy|April 10, 2010
Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularizationShu Kachi, Katie Binley, Katsutoshi Yokoi, et al.
Human Gene Therapy|January 25, 2018
Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant PatientsNaghmeh Fouladi, Maria Parker, Vicky Kennedy, et al.
Genomics|December 12, 2003
Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesisJonathan Richard White, Robert A Harris, Sheena R Lee, et al.
Pageof 2